• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Rubicon Founders Invests $165M in Caidya to Fuel Global Expansion

by Fred Pennic 01/13/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Rubicon Founders Invests $165M in Caidya to Fuel Global Expansion

What You Should Know: 

– Caidya, a global mid-sized clinical research organization (CRO), announced today a $165 million strategic growth investment from funds managed by Rubicon Founders, a healthcare investment firm focused on building and growing transformative companies. 

– The strategic investment will support Caidya’s continued expansion and its mission to accelerate the development of innovative therapies for unmet medical needs.

Fueling Growth and Strategic Acquisitions

Rubicon Founders’ investment will be instrumental in driving Caidya’s next phase of growth, enabling:

  • Organic expansion: Further expanding Caidya’s global footprint and service offerings.
  • Strategic acquisitions: Exploring potential acquisitions to enhance capabilities and accelerate growth.

This investment complements Caidya’s existing investors, which include leading global venture capital, private equity, and healthcare investors. David M. Glaccum, partner at Rubicon Founders, will join Caidya’s board of directors, bringing valuable expertise and guidance.

A Global CRO with a Patient-Centric Approach

With a presence in 23 countries and regions, Caidya offers full-service CRO capabilities and a strong commitment to partnering with biopharma sponsors. The company provides:

  • Access to diverse patient populations: Facilitating global clinical trials and accelerating drug development.
  • Specialized clinical research services: Expertise in oncology, hematology, rare and pediatric diseases, and other therapeutic areas with significant unmet needs.
  • Strategic partnership model: Delivering customized solutions and white-glove service to support biopharma clients.

“We are extremely excited to get Rubicon Founders’ support as Caidya embarks on our next phase of growth and transformation. Rubicon Founders will bring tremendous expertise and resources to accelerate our global growth, in full alignment with our aspiration to be the leading mid-sized CRO serving biopharma innovation across the Americas, Europe, and Asia-Pacific,” said Caidya’s Chief Executive Officer, Barbara Lopez Kunz.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |